Voicebrook’s speech-enabled workflow technology enhances the Techcyte Fusion platform, enabling more natural interaction with digital slides, AI tools, and pathology reporting.
Roslyn Heights, NY, March 10, 2026 – Voicebrook, the leader in speech-enabled reporting and workflow automation solutions for pathology, today announced a new integration partnership with Techcyte, a pioneer in AI-driven digital pathology platforms. This integration brings Voicebrook’s advanced voice-driven workflow capabilities directly into the Techcyte Fusion digital pathology environment, enabling pathologists to navigate cases, interact with slides, complete CAP checklists, manage quality control, and order stains — all by voice.
The result is a fully speech-enabled digital pathology workflow that reduces manual clicks, improves structured reporting, and keeps pathologists focused on diagnosis.
“As digital pathology adoption accelerates, reducing workflow friction becomes critical,” said Filipe Carreira, COO, Voicebrook. “By enabling hands-free navigation, structured CAP reporting, and voice-driven operational tasks within Techcyte, we’re eliminating unnecessary clicks and helping pathologists stay focused on diagnostic decision-making.”
With the joint solution, pathology teams benefit from:
- Speech-Enabled Command & Control:
Hands-free navigation of cases and slides, including zoom, pan, annotation, and tab switching, reduces clicks and keeps pathologists focused on diagnosis.
- Structured CAP Reporting Integration:
Voice-driven CAP checklist completion with automatic population into the report supports standardized, up-to-date cancer reporting aligned with evolving CAP eCP requirements.
- Streamlined Quality Control & Stain Workflows:
Voice-enabled QC documentation and stain ordering connect slide review, quality management, and operational workflows in one seamless experience.
- Reduced Workflow Friction:
Fewer manual steps improve efficiency and help maintain consistency throughout the digital case.
“Fusion AP is designed to provide pathologists with a high-performance digital workspace that supports primary diagnosis, structured reporting, and integrated AI within a single platform,” said Ben Cahoon, CEO of Techcyte. “By incorporating Voicebrook’s speech-enabled workflow capabilities into Fusion, we are further expanding our ecosystem to support more natural interaction with digital cases while preserving the flexibility laboratories expect.”
The Voicebrook-Techcyte integration is available now for pathology labs looking to streamline and improve digital pathology workflows.
###
About Voicebrook:
Voicebrook is the leading provider of speech-enabled reporting and workflow solutions purpose-built for pathology. For more than two decades, Voicebrook has helped laboratories improve reporting accuracy, standardization, and efficiency through solutions that combine advanced speech recognition, structured reporting, CAP electronic Cancer Checklists, and intelligent workflow automation. Voicebrook’s flagship solution VoiceOver PRO extends beyond traditional dictation to deliver full speech-driven workflow control across the diagnostic process — from grossing and image capture to slide review, structured reporting, and final sign-out. Through deep integrations with anatomic pathology systems, LIS platforms, and digital pathology environments, Voicebrook helps laboratories accelerate adoption of digital pathology while advancing innovation through practical, workflow-embedded AI tools that enhance productivity, quality, and diagnostic confidence.
Learn more at www.voicebrook.com.
About Techcyte:
Founded in 2013, Techcyte is transforming the practice of pathology with a unified pathology platform that digitizes lab workflows and offers AI tools that aim to improve the efficiency and accuracy of diagnostic testing. Our mission is to positively impact the health of humans, animals, and the environment through the use of artificial intelligence.
We do that by partnering with best-in-class labs, whole slide scanner manufacturers, AI vendors, diagnostic companies, hardware manufacturers, and solution providers. Together, we aim to deliver a unified anatomic and clinical pathology platform to labs and clinics around the world. Techcyte’s anatomic and clinical pathology platform is for Research Use Only in the United States.
Learn more at techcyte.com.
